The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association between bone turnover markers and skeletal-related events in patients with breast cancer and bone metastases on treatment with bisphosphonates: ZOMAR study results at nine months of follow-up.
A. Barnadas
No relevant relationships to disclose
C. De la Piedra
Research Funding - Novartis
C. Crespo
No relevant relationships to disclose
P. Gomez Pardo
No relevant relationships to disclose
L. Calvo
No relevant relationships to disclose
E. G. Calvo
No relevant relationships to disclose
M. Ruiz-Borrego
No relevant relationships to disclose
J. Rifa
No relevant relationships to disclose
L. Manso
No relevant relationships to disclose
A. Anton
No relevant relationships to disclose
M. Codes
No relevant relationships to disclose
M. Margeli
No relevant relationships to disclose
A. Murias
No relevant relationships to disclose
J. Salvador
No relevant relationships to disclose
M. A. SeguĂ­-Palmer
No relevant relationships to disclose
A. De Juan
No relevant relationships to disclose
J. Gavila
No relevant relationships to disclose
D. Perez
No relevant relationships to disclose
M. Luque
No relevant relationships to disclose
I. Tusquets
No relevant relationships to disclose